Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...

This is a developing news story. Please check back soon for updates. Tremfya reduced signs and symptoms of psoriatic ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Degenerative disc disease is common among young adults with PsA, with key risk factors including older age, male sex, diabetes, and inflammatory back pain.

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Approximately one quarter of patients with psoriatic arthritis (PsA) exhibited axial involvement (axial PsA). Enthesitis, inflammatory bowel disease, and HLA-B27 positivity were associated with an ...

ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...

Ontario residents 66 years and older with psoriatic disease were identified, and 11,641 individuals who received their first systemic therapy between April, 2002, and January, 2021, were included.

Finally, the oral tumor necrosis factor (TNF) inhibitor SAR441566 has begun clinical evaluation outside the U.S. for patients with psoriasis and rheumatoid arthritis. The first clinical results ...

A new study published in Heliyon has found that people who experienced abuse, neglect, or domestic abuse during childhood ...